We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
AbCellera Biologics Inc.
Health Care · Biotechnology
Antibody-discovery platform - single-cell microfluidics + deep-sequencing + ML to identify and optimize antibody candidates rapidly. Canadian-listed (CAD reporting). Pipeline transition underway: from pure platform-royalty model toward direct internal candidates.
Lead ABCL635 on track for Phase 2 top-line Q3 2026. Cash position CAD 531M + CAD 124M in government funding available.
Each weekday: the scan's ENTER setups with entry, stop and target, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
No spam. One email per day max. Pro adds Telegram trade alerts and higher AI-assistant limits.